1. Chua R., Tham K.F.: Will “no blood” kill Jehovah Witnesses?. Singapore Med J 47. 994-1001.2006;quiz 2
2. Acts ch.15 v. 29. The New English Bible with the Apocrypha, Oxford University PressOxford1970:
3. Dixon J.L., Smalley M.G.: Jehovah's Witnesses. The surgical/ethical challenge. JAMA 246. 2471-2472.1981;
4. Cunningham J.D., Fong Y., Shriver C., et al: One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg 129. 1050-1056.1994;
5. Jarnagin W.R., Gonen M., Fong Y., et al: Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236. 397-406.2002;discussion 407
6. Fernandez-Del Castillo C., Morales-Oyarvide V., McGrath D., et al: Evolution of the Whipple procedure at the Massachusetts General Hospital. Surgery 152. (Suppl 1): S56-S63.2012;
7. Drackley A., Newbold K.B., Paez A., Heddle N.: Forecasting Ontario's blood supply and demand. Transfusion 52. 366-374.2012;
8. Emmert M.Y., Salzberg S.P., Theusinger O.M., et al: How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery. Interactive Cardiovasc Thorac Surg 12. 183-188.2011;
9. Barakat O., Cooper , Jr. , Jr.J.R., Riggs S.A., et al: Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's witness: a strategy to avoid transfusion. J Surg Oncol 96. 249-253.2007;
10. Shiozawa S., Haga S., Kumazawa K., et al: Pylorus-preserving pancreaticoduodenectomy without homologous blood transfusion in a Jehovah's witness with pancreatic cancer: report of a case. Hepatogastroenterology 50. 272-274.2003;
11. Jabbour N., Gagandeep S., Mateo R., et al: Transfusion free surgery: single institution experience of 27 consecutive liver transplants in Jehovah's Witnesses. J Am Coll Surg 201. 412-417.2005;
12. Jabbour N., Gagandeep S., Bramstedt K.A., et al: To do or not to do living donor hepatectomy in Jehovah's Witnesses: single institution experience of the first 13 resections. Am J Transplant 5. 1141-1145.2005;
13. Jarnagin W.R., Gonen M., Maithel S.K., et al: A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg 248. 360-369.2008;
14. Fischer M., Matsuo K., Gonen M., et al: Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management. Ann Surg 252. 952-958.2010;
15. Carless P.A., Henry D.A., Moxey A.J., et al: Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev . (4): CD001888.2010;
16. Marsh J.C., Bevan D.H.: Haematological care of the Jehovah's Witness. Br J Haematol 119. 25-37.2002;
17. Tonia T., Mettler A., Robert N., et al: Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev 12. CD003407.2012;
18. Melendez J.A., Arslan V., Fischer M.E., et al: Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 187. 620-625.1998;
19. Jayaraman S., Gonen M., Brennan M.F., et al: Laparoscopic distal pancreatectomy: evolution of a technique at a single institution. J Am Coll Surg 211. 503-509.2010;
20. Martin , 2nd , 2ndR.C., Brennan M.F., Jaques D.P.: Quality of complication reporting in the surgical literature. Ann Surg 235. 803-813.2002;
21. Man K., Fan S.T., Ng I.O., et al: Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 226. 704-711.1997;discussion 711–713
22. Bui L.L., Smith A.J., Bercovici M., et al: Minimising blood loss and transfusion requirements in hepatic resection. HPB (Oxford) 4. 5-10.2002;
23. Lentschener C., Gomola A., Grabar S., et al: The effect of erythropoietin on allogeneic blood requirement in patients undergoing elective liver resection: a model simulation. Anesthes Analg 98. 921-926.2004;
24. Wu C.C., Ho W.M., Cheng S.B., et al: Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a “blood transfusion”-free hepatectomy. Ann Surg 243. 173-180.2006;
25. Gorlinger K., Dirkmann D., Hanke A.A., et al: First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 115. 1179-1191.2011;
26. Huang Z.Q., Xu L.N., Yang T., et al: Hepatic resection: an analysis of the impact of operative and perioperative factors on morbidity and mortality rates in 2008 consecutive hepatectomy cases. Chin Med J 122. 2268-2277.2009;
27. Cescon M., Vetrone G., Grazi G.L., et al: Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 249. 995-1002.2009;
28. Poon R.T., Fan S.T., Lo C.M., et al: Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 240. 698-708.2004;discussion 710
29. Ahmad S.A., Edwards M.J., Sutton J.M., et al: Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg 256. 529-537.2012;
30. Waters J.H., Yazer M., Chen Y.F., Kloke J.: Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion 52. 2167-2173.2012;
31. Correa-Gallego C., Brennan M.F., D'Angelica M., et al: Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg . 2013 Jan 28;[Epub ahead of print]
32. Goodnough L.T., Shander A., Brecher M.E.: Transfusion medicine: looking to the future. Lancet 361. 161-169.2003;
33. Vamvakas E.C., Blajchman M.A.: Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 113. 3406-3417.2009;
34. Isbister J.P., Shander A., Spahn D.R., et al: Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev 25. 89-101.2011;
35. Acheson A.G., Brookes M.J., Spahn D.R.: Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 256. 235-244.2012
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.